Literature DB >> 28767198

Optimal cut-off score of the Edinburgh Postnatal Depression Scale for major depressive episode during pregnancy in Japan.

Kentaro Usuda1,2, Daisuke Nishi1,2, Emi Okazaki1,2, Miyuki Makino3, Yo Sano1.   

Abstract

AIM: Depression during pregnancy adversely affects both mother and child. As antenatal depression is a predictor of postnatal depression, early detection might prevent postnatal depression. The Edinburgh Postnatal Depression Scale (EPDS) is frequently used during the perinatal period, but the cut-off score during pregnancy has not been verified for the Japanese population. We aimed to clarify the optimal EPDS cut-off score in mid-pregnancy in Japan.
METHODS: We recruited pregnant women aged 20 years or older at 12-24 gestational weeks and those who scored ≥9 on the EPDS were invited to participate in this study. In parallel with the EPDS, the Japanese version of the Mini-International Neuropsychiatric Interview was administered to determine diagnosis of major depressive episode. We then calculated the receiver-operator curve, sensitivity and specificity, and positive and negative predictive values for the EPDS.
RESULTS: All 210 participants were in the second trimester except for one (12 gestational weeks). Twenty participants were diagnosed with major depressive episode. With a cut-off score set at 13 points, the area under the curve was 0.956; sensitivity and specificity were 90.0% and 92.1% [Correction added on 10 November 2017, after first online publication: The percentage for specificity has been corrected from 79.0% to 92.1%.], respectively; and positive and negative predictive values were 54.5% and 98.9%, respectively.
CONCLUSION: To our knowledge, this is the first study to clarify the optimal EPDS cut-off score in the second trimester for Japan. This finding will be helpful for appropriate screening for antenatal depression in Japan.
© 2017 The Authors. Psychiatry and Clinical Neurosciences © 2017 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  Edinburgh Postnatal Depression Scale; cut-off score; screening; second trimester; validity

Mesh:

Year:  2017        PMID: 28767198     DOI: 10.1111/pcn.12562

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  16 in total

Review 1.  Prevalence of perinatal depression among Japanese women: a meta-analysis.

Authors:  Keita Tokumitsu; Norio Sugawara; Kazushi Maruo; Toshihito Suzuki; Kazutaka Shimoda; Norio Yasui-Furukori
Journal:  Ann Gen Psychiatry       Date:  2020-06-26       Impact factor: 3.455

2.  Validation and factor structure of the Japanese version of the inventory to diagnose depression, lifetime version for pregnant women.

Authors:  Chika Kubota; Toshiya Inada; Yukako Nakamura; Tomoko Shiino; Masahiko Ando; Branko Aleksic; Aya Yamauchi; Mako Morikawa; Takashi Okada; Masako Ohara; Maya Sato; Satomi Murase; Setsuko Goto; Atsuko Kanai; Norio Ozaki
Journal:  PLoS One       Date:  2020-06-11       Impact factor: 3.240

3.  Stable factor structure of the Edinburgh Postnatal Depression Scale during the whole peripartum period: Results from a Japanese prospective cohort study.

Authors:  Chika Kubota; Toshiya Inada; Yukako Nakamura; Tomoko Shiino; Masahiko Ando; Branko Aleksic; Aya Yamauchi; Mako Morikawa; Takashi Okada; Masako Ohara; Maya Sato; Satomi Murase; Setsuko Goto; Atsuko Kanai; Norio Ozaki
Journal:  Sci Rep       Date:  2018-12-05       Impact factor: 4.379

4.  Methylation analysis for postpartum depression: a case control study.

Authors:  Yukako Nakamura; Masahiro Nakatochi; Shohko Kunimoto; Takashi Okada; Branko Aleksic; Miho Toyama; Tomoko Shiino; Mako Morikawa; Aya Yamauchi; Akira Yoshimi; Yoko Furukawa-Hibi; Taku Nagai; Masako Ohara; Chika Kubota; Kiyofumi Yamada; Masahiko Ando; Norio Ozaki
Journal:  BMC Psychiatry       Date:  2019-06-20       Impact factor: 3.630

5.  Psychometric properties of the Arabic version of EPDS and BDI-II as a screening tool for antenatal depression: evidence from Qatar.

Authors:  Sarah Naja; Noora Al-Kubaisi; Mohamad Chehab; Ayman Al-Dahshan; Nada Abuhashem; Iheb Bougmiza
Journal:  BMJ Open       Date:  2019-09-13       Impact factor: 2.692

6.  Retrospective follow-up analysis of the transcriptomic patterns of cytokines, cytokine receptors and chemokines at preconception and during pregnancy, in women with post-partum depression.

Authors:  Maria Cristina Petralia; Emanuela Mazzon; Paolo Fagone; Luca Falzone; Placido Bramanti; Ferdinando Nicoletti; Maria Sofia Basile
Journal:  Exp Ther Med       Date:  2019-07-12       Impact factor: 2.447

7.  Depressive Symptoms in Late Pregnancy Disrupt Attentional Processing of Negative-Positive Emotion: An Eye-Movement Study.

Authors:  Weina Tang; Ciqing Bao; Ling Xu; Jie Zhu; Wenqian Feng; Wenmiao Zhang; Cong Lin; Lan Chen; Qianqian Cheng; Penghao Ding; Meixi Zhou; Ying Bao; Xin Yu; Ke Zhao; Jincai He
Journal:  Front Psychiatry       Date:  2019-10-31       Impact factor: 4.157

8.  Anxiety, Prenatal Attachment, and Depressive Symptoms in Women with Diabetes in Pregnancy.

Authors:  Angela Napoli; Dorian A Lamis; Isabella Berardelli; Valeria Canzonetta; Salvatore Sarubbi; Elena Rogante; Pietro-Luca Napoli; Gianluca Serafini; Denise Erbuto; Renata Tambelli; Mario Amore; Maurizio Pompili
Journal:  Int J Environ Res Public Health       Date:  2020-01-08       Impact factor: 3.390

9.  Impact of intention and feeling toward being pregnant on postpartum depression: the Japan Environment and Children's Study (JECS).

Authors:  Sachiko Baba; Takashi Kimura; Satoyo Ikehara; Kaori Honjo; Ehab S Eshak; Takuyo Sato; Hiroyasu Iso
Journal:  Arch Womens Ment Health       Date:  2018-12-27       Impact factor: 3.633

10.  Psychosocial factors associated with postpartum psychological distress during the Covid-19 pandemic: a cross-sectional study.

Authors:  Luca Ostacoli; Stefano Cosma; Federica Bevilacqua; Paola Berchialla; Marialuisa Bovetti; Andrea Roberto Carosso; Francesca Malandrone; Sara Carletto; Chiara Benedetto
Journal:  BMC Pregnancy Childbirth       Date:  2020-11-18       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.